Until recently, thyroid cancer was one of the most rapidly increasing cancers in the United States. Disparities exist in many aspects of thyroid cancer care as a result of the multifactorial interplay of systemic, patient, and physician factors. To better understand the management of thyroid cancer in populations at risk for health disparities and subsequently implement changes that will lead to health equity for all patients with thyroid cancer, health services research with innovative approaches is necessary.
Get full access to this article
View all access options for this article.
References
1.
National Institute on Minority Health and Health Disparities. Health disparity populations. Available at https://www.nimhd.nih.gov/about/overview/ (accessed January1, 2020).
2.
United States Census Bureau. Available at https://www.census.gov/en.html (accessed January1, 2020).
3.
The Williams Institute, UCLA School of Law. How many people are lesbian, gay, bisexual, and transgender? Available at https://williamsinstitute.law.ucla.edu/wp-content/uploads/Gates-How-Many-People-LGBT-Apr-2011.pdf (accessed January1, 2020).
4.
ShahSA, AdamMA, ThomasSM, ScheriRP, StangMT, SosaJA, RomanSA. 2017. Racial disparities in differentiated thyroid cancer: have we bridged the gap?. Thyroid, 27:762–772.
5.
WenaasAE, NagyCZ, YiuY, XuL, HorterK, ZevallosJP. 2015. Demographic and socioeconomic factors predictive of compliance with American Thyroid Association guidelines for the treatment for advanced papillary thyroid carcinoma. Head Neck, 37:1776–1780.
6.
WeeksKS, KahlAR, LynchCF, CharltonME. 2018. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007–2014. Cancer, 124:1483–1491.
7.
HarariA, LiN, YehMW. 2014. Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer. J Clin Endocrinol Metab, 99:133–141.
8.
SosaJA, MehtaPJ, WangTS, YeoHL, RomanSA. 2007. Racial disparities in clinical and economic outcomes from thyroidectomy. Ann Surg, 246:1083–1091.
9.
SosaJA, BowmanHM, TielschJM, PoweNR, GordonTA, UdelsmanR. 1998. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg, 228:320–330.
10.
HaymartMR, BanerjeeM, StewartAK, KoenigRJ, BirkmeyerJD, GriggsJJ. 2011. Use of radioactive iodine for thyroid cancer. JAMA, 306:721–728.
11.
PapaleontiouM, Reyes-GastelumD, GayBL, WardKC, HamiltonAS, HawleyST, HaymartMR. 2019. Worry in thyroid cancer survivors with a favorable prognosis. Thyroid, 29:1080–1088.
12.
ChenDW, Reyes-GastelumD, WallnerLP, PapaleontiouM, HamiltonAS, WardKC, HawleyST, Zikmund-FisherBJ, HaymartMR. 2019. Disparities in risk perception of thyroid cancer recurrence and death. Cancer, 126:1512–1521.
13.
National Institute of Health. Improving smoking cessation in socioeconomically disadvantaged populations via scalable interventions. Available at https://grants.nih.gov/grants/guide/pa-files/par-18-250.html (accessed January1, 2020).
14.
ZevallosJP, XuL, YiuY. 2014. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer. Thyroid, 24:758–763.
15.
UllmannTM, GrayKD, LimbergJ, StefanovaD, MooreMD, BuickoJ, FinnertyB, ZarnegarR, FaheyTJ, BeninatoT. 2019. Insurance status is associated with extent of treatment for patients with papillary thyroid carcinoma. Thyroid, 29:1784–1791.
16.
MotenAS, ZhaoH, IntenzoCM, WillisAI. 2019. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients. Eur J Surg Oncol, 45:2090–2095.
17.
ZahndWE, JamesAS, JenkinsWD, IzadiSR, FoglemanAJ, StewardDE, ColditzGA, BrardL. 2018. Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomarkers Prev, 27:1265–1274.
18.
McDowAD, ZahndWE, AngelosP, MellingerJD, GanaiS. 2020. Impact of rurality on national trends in thyroid cancer incidence and long-term survival. J Rural Health, 36:326–333.
19.
National Institute of Health. Plans for advancing LGBT health research. Available at https://www.nih.gov/about-nih/who-we-are/nih-director/statements/plans-advancing-lgbt-health-research (accessed January1, 2020).
20.
GriggsJ, MaingiS, BlinderV, DenduluriN, KhoranaAA, NortonL, FranciscoM, WollinsDS, RowlandJH. 2017. American Society of Clinical Oncology position statement: strategies for reducing cancer health disparities among sexual and gender minority populations. J Clin Oncol, 35:2203–2208.
21.
GomezSL, DuffyC, GriggsJJ, JohnEM. 2019. Surveillance of cancer among sexual and gender minority populations: Where are we and where do we need to go?. Cancer, 125:4360–4362.
22.
Institute of Medicine Committee on LesbianG, Bisexual, and Transgender Health Issues and Research Gaps andOpportunities. 2011. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding. National Academies Press, Washington.
23.
National Institute of Health. Sexual and gender minority populations in NIH-supported research. Available at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-139.html (accessed January1, 2020).
24.
LubitzCC, KongCY, McMahonPM, DanielsGH, ChenY, EconomopoulosKP, GazelleGS, WeinsteinMC. 2014. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer, 120:1345–1352.
25.
BarrowsCE, BelleJM, FleishmanA, LubitzCC, JamesBC. 2020. Financial burden of thyroid cancer in the United States: An estimate of economic and psychological hardship among thyroid cancer survivors. Surgery, 167:378–384.
26.
WhiteMG, ApplewhiteMK, KaplanEL, AngelosP, HuoD, GroganRH. 2017. A tale of two cancers: traveling to treat pancreatic and thyroid cancer. J Am Coll Surg, 225:125–136.
27.
SantryHP, WrenSM. 2012. The role of unconscious bias in surgical safety and outcomes. Surg Clin North Am, 92:137–151.
28.
ChapmanEN, KaatzA, CarnesM. 2013. Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities. J Gen Intern Med, 28:1504–1510.
29.
DaviesL, WelchHG. 2006. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA, 295:2164–2167.
30.
HaymartMR, BanerjeeM, Reyes-GastelumD, CaoiliE, NortonEC. 2019. Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer. J Clin Endocrinol Metab, 104:785–792.
31.
EsfandiariNH, HughesDT, Reyes-GastelumD, WardKC, HamiltonAS, HaymartMR. 2019. Factors associated with diagnosis and treatment of thyroid microcarcinomas. J Clin Endocrinol Metab, 104:6060–6068.
32.
MagreniA, BannDV, SchubartJR, GoldenbergD. 2015. The effects of race and ethnicity on thyroid cancer incidence. JAMA Otolaryngol Head Neck Surg, 141:319–323.
33.
MillerKD, Goding SauerA, OrtizAP, FedewaSA, PinheiroPS, Tortolero-LunaG, Martinez-TysonD, JemalA, SiegelRL. 2018. Cancer statistics for hispanics/latinos, 2018. CA Cancer J Clin, 68:425–445.
34.
KotwalA, BleyerA, BritoJP. 2019. Thyroid cancer incidence continues to rise but mortality remains stable in young, hispanic, and black populations in the United States. Endocr Pract, 25:115–116.
35.
ZagzagJ, KenigsbergA, PatelKN, HellerKS, OgilvieJB. 2017. Thyroid cancer is more likely to be detected incidentally on imaging in private hospital patients. J Surg Res, 215:239–244.
36.
American Cancer Society. Cancer health disparities research. Available at https://www.cancer.org/research/currently-funded-cancer-research/cancer-health-disparities-research.html (accessed January20, 2020).
37.
Association of American Medical Colleges. Health equity grants and funding opportunities. Available at https://www.aamc.org/what-we-do/mission-areas/medical-research/health-equity/funding-opportunities (accessed January1, 2020).
38.
American Cancer Society. Key statistics for thyroid cancer. Available at https://www.cancer.org/cancer/thyroid-cancer/about/key-statistics.html (accessed January1, 2020).
